These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31448438)

  • 21. A rare case of childhood mucous membrane pemphigoid involving the oral and genital mucosa.
    Rodriguez Baisi K; Wentworth A; Chattha AJ; DiCaudo DJ; Mangold A; Nelson SA; Siegfried E; Wieland CN; Tollefson M
    Pediatr Dermatol; 2021 Jul; 38(4):904-907. PubMed ID: 33977558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgM ocular cicatricial pemphigoid: a unique insight into the immune system.
    Tazudeen N; Au S; Pewitt J; Tu E; Aronson IK
    Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current medical treatment of ocular mucous membrane pemphigoid.
    Sobolewska B; Deuter C; Zierhut M
    Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy.
    Buonavoglia A; Leone P; Dammacco R; Di Lernia G; Petruzzi M; Bonamonte D; Vacca A; Racanelli V; Dammacco F
    Autoimmun Rev; 2019 Apr; 18(4):349-358. PubMed ID: 30738958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
    Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of rituximab in the treatment of mucous membrane pemphigoid: An analytic review.
    Farooq MM; Miloslavsky EM; Konikov N; Ahmed AR
    Autoimmun Rev; 2022 Aug; 21(8):103119. PubMed ID: 35688385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-laminin 332 mucous membrane pemphigoid in a young woman treated with rituximab.
    Gitin A; Porta AD; Bisbee E; Braunlich K; Motaparthi K
    Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
    Li Y; Foshee JB; Sontheimer RD
    J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab for the Treatment of Isolated Refractory Desquamative Gingivitis Due to Mucous Membrane Pemphigoid.
    Haefliger S; Horn MP; Suter VG; Bornstein MM; Borradori L
    JAMA Dermatol; 2016 Dec; 152(12):1396-1398. PubMed ID: 27732708
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
    Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
    [No Abstract]   [Full Text] [Related]  

  • 31. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
    Shetty S; Ahmed AR
    J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid.
    Rashid H; Meijer JM; Bolling MC; Horváth B
    Br J Dermatol; 2022 Apr; 186(4):721-723. PubMed ID: 34747507
    [No Abstract]   [Full Text] [Related]  

  • 33. Laryngeal mucous membrane pemphigoid: transnasal laryngoscopy to highlight a severe case.
    Watters CTM; Miller B; Karagama Y
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33334770
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab.
    He Y; Shimoda M; Ono Y; Villalobos IB; Mitra A; Konia T; Grando SA; Zone JJ; Maverakis E
    JAMA Dermatol; 2015 Jun; 151(6):646-50. PubMed ID: 25901938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical Occlusive Corticosteroid Therapy for the Treatment of Gingival Manifestation of Mucous Membrane Pemphigoid - a Case Report.
    Kavlakova L; Bachurska S
    Folia Med (Plovdiv); 2020 Dec; 62(4):866-870. PubMed ID: 33415936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mucous membrane pemphigoid: a review].
    Bédane C; Doffoel Hantz V
    Ann Dermatol Venereol; 2011 Mar; 138(3):201-8. PubMed ID: 21397149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review.
    Lytvyn Y; Rahat S; Mufti A; Witol A; Bagit A; Sachdeva M; Yeung J
    J Am Acad Dermatol; 2022 Jul; 87(1):110-120. PubMed ID: 33422625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucous membrane pemphigoid-otorhinolaryngological manifestations: a retrospective cohort study.
    Madgar O; Baniel A; Yarom N; Glikson E; Zeeli T; Sprecher E; Alon EE
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):939-945. PubMed ID: 31980882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome and safety of rituximab therapy for pemphigoid diseases.
    Tovanabutra N; Payne AS
    J Am Acad Dermatol; 2020 May; 82(5):1237-1239. PubMed ID: 31738960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.